TRDN and familial long QT syndrome: Other rare alterations have been reported in minor genes, accounting for 5% of LQTS (CACNA1C, CALM1, CALM2, CALM3, and TRDN), whereas about 20% of all diagnosed patients do not have an identifiable deleterious variant in any of the current known genes related to LQTS (3).